K-BIO Institut für Zellbiotechnologie und Immunologie GmbH

Company

    • Company type:
      • Manufacturer
      • Research & Development
      • Service Provider
    • Year founded:
    • 2000
    • Employees (at the site):
    • not available
    • Turnover range:
    • not available
    • Products/services:
    • R&D in immunology, Biochemistry, e.g. Aseptic, standardized blood-treatment procedure AHICE for the autologous immune-response, autologous Vaccine AHICE (special kind of hemodialysis for elimination of the "escape machanisms of cancer cells to became them recognizeable by the autologous immune system) for tumor-treatment, tumor-after-care, as also for the treatment of auto-immune-diseases.
      - Applied research on cell-biological, immunological / biochemical scientific areas and development of the prognostic and predictive immunological biomarkers at cancer-cells as well as cellbiological / molecular-biological / biochemical applied research for the enlightenment of further Escape-Mechanisms of the tumor-cells.

    • Core competencies:
    • R&D in Onco-Immunology, biochemistry, cell-biology, radiobiology, Auto-Immune-Response-Mechanisms, Research in Escape-Mechanisms of tumor-cells, medical lab diagnostics.
      - Research& Developement of Preparation-Methods for Immunotherapies of Cancer, e. g. of the autologous human Vaccine AHICE (special kind of the hemodialysis) for the treatment of tumors and auto-immune-diseases.
      - Scientifical Research for further Biomarkers of the tumor-cells for their prediktive, prognostic recognition.

    • Language skills:
    • English
      German
      Greek
    • Key Tech / section:
      • Biotechnology: Analytics and separation technology
      • Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
      • Biotechnology: Prophylactic drug development
      • Biotechnology: Therapeutic drug development
      • Biotechnology: Tissue engineering and regenerative medicine
    • Industries NACE:
      • 21: Manufacture of basic pharmaceutical products and pharmaceutical preparations
      • 21.2: Manufacture of pharmaceutical preparations
      • 72: Scientific research and development
      • 72.1: Research and experimental development on natural sciences and engineering
      • 72.11: Research and experimental development on biotechnology
    • Certification:
    • Nach GMP-Leitfaden, AMG und AMWHV

    • Sales markets - target industries:
    • Ärzte /Kliniken/ Krankenhäuser, die für die Therapie der betreffenden Patienten verantwortlich sind - Pharma Auftrags-Forschung &Entwicklung in Biotechnologie/Immunologie..
    • Sales markets - target countries:
      • Australia
      • Bahrain
      • Brunei Darussalam
      • Cyprus
      • Jordan
      • Kuwait
      • Myanmar
      • New Zealand
      • Oman
      • Qatar
      • Russian Federation
      • Saudi Arabia
      • Singapore
      • South Africa
      • Taiwan, Province of China
      • Thailand
      • Turkey
      • United Arab Emirates
      • United Kingdom
      • United States
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Hannes Anthopoulos (Mr.)
      - Management
      - Sales / marketing
      - Purchasing
      - Research & development
      - Cooperation